Half Yearly Report

Animalcare Group plc

("Animalcare" or "the Group" or "the Company")

Unaudited Interim Results for the six months ended 31 December 2010

Animalcare, the supplier of pharmaceutical and other premium products and services to the veterinary industry, announces its interim results for the six months ended 31 December 2010, with continuing strong results for the continuing operations and the payment of a maiden interim dividend.

Following the completion of the sale during the period of the Ritchey, Fearing and Travik businesses, which together comprised the livestock division, Animalcare is now focused entirely on the supply of products to veterinary professionals principally for use in companion animal markets.

Highlights

* Underlying measures exclude, where applicable, amortisation of acquired intangibles, impairment of goodwill, fair value movements on interest hedging, impairments to current and non-current assets and other charges relating to Group reorganisation.

Other highlights

·; Focus on core companion animal veterinary medicines and identification business with earnings less affected by seasonal fluctuations

·; Revenue growth in the period strongly ahead of the projected overall growth in the companion animal market

·; Maiden interim dividend of 1.0 pence per share

·; Strong product pipe line of new licensed veterinary medicines with two new products launched in H1 2011 and at least two launches planned in H2 2011

·; Substantial operational cashflow with all borrowings expected to be fully repaid by 31 March 2011

Commenting on outlook, James Lambert, Chairman of Animalcare, said:

"The first six months of this financial year has seen the completion of the transformation of your business to a high margin focused companion animal veterinary products business which is in a net cash position and will be debt free by 31 March 2011. The Board believes that trading in the second half is in line with market expectations."

CHAIRMAN'S STATEMENT

I am pleased to report continuing strong results for the continuing operations of Animalcare Group plc during the six months ended 31 December 2010, after the completion of the sale of Ritchey, Fearing and Travik businesses, which together comprised our livestock division, during the period which means the Company is focused entirely on the companion animal market. The proceeds of these sales have left your Company with net cash at the interim stage.

Revenue from continuing operations improved by twelve per cent, almost entirely driven by new pharmaceutical products, which increased profit before tax from continuing operations up from £0.94m to £1.38m and total basic earnings per share up from 2.8 pence to 4.8 pence, an impressive 71 per cent increase year on year. With earnings less affected by seasonal fluctuations, after the sale of the more seasonally affected livestock businesses, your board is proposing to pay an interim dividend of 1.0 pence per share on 6 June 2011 to all shareholders on the register on 13 May 2011.

Although the companion animal veterinary medicines market continued to grow in 2010 estimated at around 1.5 per cent, the growth is lower than in the recent past. The market's growth is being maintained by owners continuing willingness to care for their pets and the increasing numbers of new treatments and products entering the market. Your Board expects the growth of the market to continue at approximately these levels for the remainder of 2011. We are confident however that Animalcare's growth will be stronger through further sales of recently launched products and planned launches, of new generic licensed veterinary medicines.

With the completion of the sale of the Livestock businesses Geoff Rhodes, their former CEO, retired from the Board as a non executive director. I would like to thank him for his enormous contribution he made in building them into a leading UK agricultural supply business.

Your company continues to develop a pipe line of new licensed veterinary medicines and should launch at least two more products during the second half of the year in market segments where the company already has a good complementary presence. There is potential to launch up to two more products before the end of the period and we will decide on this shortly.

The first six months of this financial year has seen the completion of the transformation of your business to a high margin focused companion animal business which is in a net cash position and which will be debt free by 31 March 2011. The Board believes that trading in the second half is in line with market expectations.

James Lambert

Chairman

FINANCIAL REVIEW

Group Overview

The Group disposed of its entire livestock division during the six months ended 31 December 2010. As a consequence, total Group revenues and gross profit fell below the values for the six months ended 31 December 2009 ("2009"), but the marginally profitable nature of the livestock division and the improving profitability in the continuing companion animal division saw the underlying profit before tax for the six months ended 31 December 2010 rise to £1.01m (2009 - £0.61m).

Continuing Operations

Revenue in the six months ended 31 December 2010 was £5.99m (2009 - £5.37m) and gross profit was £3.22m (2009 - £2.88m), representing growth of 12 per cent for both measures. The main driver for this was the growth in licensed veterinary medicines.

Distribution costs rose to £0.15m (2009 - £0.13m) as a consequence of increased sales volumes and administrative expenses fell to £1.58m (2009 - £1.63m) principally due to higher spend on new product development in the comparative period for 2009. This expenditure tends by its nature to occur in an irregular pattern. Operating profit from continuing operations rose as a consequence to £1.43m (2009 - £1.06m)

Disposals

On 17 September 2010 the Company sold the business and assets of its trading division, Ritchey, and the shares of its wholly owned subsidiary, Fearing International (Stock Aids) Limited. The expected gross consideration was £3.25m, based on the audited accounts for these businesses at 30 June 2010 and subject to completion accounting. The Group received £0.52m as working capital inflows prior to the sale and £2.51m in cash from the purchaser, which included an agreed reduction in the consideration of £0.20m in respect of unanticipated difficult trading conditions and profit shortfall in a key new product. The costs of disposal were £0.07m. All the consideration was received in cash by 31 December 2010.

On 17 November 2010 the Group sold the trade and assets of its loss making subsidiary, Travik Chemicals Limited (now Naychem Limited), for a total consideration of £0.05m net of costs. The Group retains the freehold of the Newton Aycliffe property, which has been leased to the new owner of the Travik business.

Cash Flow

Earnings before interest, taxation, depreciation and amortisation ("EBITDA") for the six months ended 31 December 2010 was £1.58m (2009 - £1.21m), this improvement was despite the loss of £0.23m on the disposal of the livestock businesses. Working capital showed a reduction of £0.01m (2009 - £0.13m), a substantial reduction in trade receivables being offset by a reduction in VAT and other liabilities following the sale of the livestock businesses. Income taxes paid were £0.41m (2009 - £0.18m), reflecting the increase in the Group's taxable profits. Interest paid was £0.11m (2009 - £0.07m), the Group has now fully settled its interest rate hedge. Overall, net cash flow from operating activities was £1.33m (2009 - £0.93m).

Capital expenditure was £0.04m (2009 - £0.40m), due to the sale of the livestock businesses and timing of expenditure on intangible assets in the continuing operations. Share proceeds generated £0.14m (2009 - £0.07m) with the issue of 238,308 ordinary shares in respect of approved employee share options. The sale of the livestock businesses generated net proceeds of £2.49m. These proceeds, together with cash generated from operations, enabled the Group to repay £3.46m (2009 - £0.39m) of its bank loans. A dividend of £0.61m (2009 - £0.49m) was paid in December 2010.

As at 31 December 2010, the Group's outstanding bank loan balance was £1.00m (2009 - £5.07m), £0.75m of which was repaid early on 8 February 2011, with the remaining balance due to be settled on 31 March 2011. As at 31 December 2010 the Group had cash balances of £1.43m (2009 - £1.25m).

Peter Warner

Chief Financial Officer

1. GENERAL INFORMATION

Animalcare Group plc ("the Group") is a company incorporated in England and Wales under the Companies Act 2006 and is domiciled in the United Kingdom. The Group comprises Animalcare Group plc and its subsidiaries. The nature of the Group's operations and its principal activities are set out in the Chairman's Statement.

This Interim Report does not constitute statutory accounts as defined in Section 435 of the Companies Act 2006. The information contained herein has not been reviewed by the Group's auditors.

The prior year comparatives are derived from the audited financial information as set out in the Group's Annual Report for the year ended 30 June 2010 and the unaudited financial information in the Groups Interim Report for the six months ended 30 June 2009. The comparative figures for the financial year ended 30 June 2010 are not the Group's statutory accounts. Those accounts have been reported on by the Groups auditors and delivered to the Registrar of Companies. The report of the auditors was unqualified, did not include any reference to matters to which the auditors drew attention without qualifying their report and did not contain a statement under section 498(2) or (3) of the Companies Act 2006.

This Interim Report for the six months ended 31 December 2010 was approved by the Board of Directors on 17 February 2011.

2. SIGNIFICANT ACCOUNTING POLICIES

Basis of preparation

The interim financial information has been prepared on the basis of the recognition and measurement requirements of International Financial Reporting Standards as adopted by the EU ("IFRS") as at 31 December 2010 that are effective (or available for early adoption) as at 30 June 2011. Based on these adopted IFRSs, the directors have applied the accounting policies, as set out below, which they expect to apply to the annual IFRS financial statements for the year ending 30 June 2011. However, the adopted IFRSs that will be effective (or available for early adoption) in the annual financial statements for the year ending 30 June 2011 are still subject to change and to additional interpretations and therefore cannot be determined with certainty. Accordingly, the accounting policies for that annual period will be determined finally only when the annual financial statements are prepared for the year ending 30 June 2011.

Accounting policies

The accounting policies applied to the Interim Results for the six months ended 31 December 2010 are consistent with those of the Company's annual accounts for the year ended 30 June 2010 with the exception of the items noted below:

Amendments to IFRS 2 Share based payments - Group Cash settled Share based payment transactions. Effective for periods starting on or after 1 January 2010

Improvements to IFRSs 2009 - amendments to various standards. Effective for periods starting on or after 1 January 2010

These amendments are not expected to have a material impact on the financial statements of the group.

Going concern

The principal risks and uncertainties facing the Group remain those set out in the latest Annual Report.

Following the sale of the Group's livestock businesses in the current period for cash, the Group reduced the balance of its outstanding loan facility to £1.0million (30 June 2010 - £4.46millon). By agreement with the bank, the repayment term of this loan was reduced to twelve months from 31 December 2010, repayable in four equal quarterly instalments of £0.25m by 31 December 2011. On 8 February 2011 the Group made an early repayment of £0.75m of this loan, meaning that the loan will be settled in full on 31 March 2011. Additionally, the Group has an undrawn overdraft facility of £100,000 which is available for general corporate and working capital requirements. At 31 December 2010 the Group had cash on hand of £1.43 million (30 June 2010 - £1.56 million), leaving it in a net cash position. In the directors' opinion, the Group's working capital requirements can be met from operating cash flow.

Overall, the directors believe the Group is well placed to manage its business risks successfully despite the current uncertain economic outlook. The Group's forecasts and projections, taking account of reasonably possible changes in trading performance, show that the Group should be able to operate within the level of its current committed facilities.

After making enquiries, the directors have a reasonable expectation that the Company and the Group have adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

3. DISCONTINUED OPERATIONS

On 17 September 2010 the Company disposed of the business and assets of its trading division, Ritchey, and the shares of its wholly owned subsidiary, Fearing International (Stock Aids) Limited. On 17 November 2010 the Group sold its loss making subsidiary, Travik Chemicals Limited. These sales comprised the whole of the Group's Livestock division. Comparative figures for the discontinued operations are set out below.

6. REVENUE AND OPERATING SEGMENTS

At the start of the current period, the principal activities of the Group were as follows:

The Companion Animal Division supplied and distributed veterinary medicines, identification and other welfare products to veterinary markets; and

The Livestock Division manufactured and distributed livestock identification and welfare products to agricultural merchants, retailers and farmers.

As referred to in Note 3 above, during the period the whole of the Livestock division was disposed of. Subsequently, the CODM considers the Companion Animal Division to constitute one operating and reporting segment as defined under IFRS 8. The CODM reviews the performance of the Group by reference to group-wide results against budget. The group-wide profit measures are gross profit and operating profit, both disclosed on the face of the consolidated statement of comprehensive income. Accordingly, no separate segmental analysis is provided.

7. INCOME TAX EXPENSE

The charge for taxation is based on an estimate of the likely effective tax rate for the year ending 30 June 2011 of 27% (year ended 30 June 2010 28%, 6 months ended 31 December 2009 32%).

10. CAUTIONARY STATEMENT

This Interim Management Report ("IMR") consists of the Chairman's Statement and Financial Review, which have been prepared solely to provide additional information to shareholders to assess the Group's strategies and the potential for those strategies to succeed. The IMR should not be relied upon by any other party or for any other purpose.

The IMR contains a number of forward looking statements. These statements are made by the directors in good faith based upon the information available to them up to the time of their approval of this report and such statements should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying any such forward looking information.

This IMR has been prepared for the Group as a whole and therefore emphasises those matters which are significant to Animalcare Group plc and its subsidiaries when viewed as a whole.

11. INTERIM REPORT

The Group's Interim Report for the six months ended 31 December 2010 is expected to be posted to shareholders on 24 February 2011 and will be available to download from its website www.animalcaregroup.co.uk. Copies will also be available from the Group's head office at Common Road, Dunnington, York, YO19 5RU.